Ristegra Dispersible Tablets 10 mg Dispersible Tablet
PDF Leaflet Revision Date: 21 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in combination with other antiretroviral medicines.
Dosage (summary)
Adults: 30 mg once daily or twice daily if resistant. Children: Dosing based on weight.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in first trimester; use with caution in pregnancy and breastfeeding.
Key Drug Interactions
- Etravirine, Efavirenz, Nevirapine, Rifampicin, Carbamazepine
Contraindications
- Hypersensitivity to dolutegravir
- Severe hepatic impairment
- Co-administration with dofetilide and pilsicainide
Common side effects
- Insomnia
- Headache
- Nausea
- Rash
- Fatigue
Counselling Points
- Take with or without food.
- Monitor for signs of hypersensitivity.
- Use effective contraception in women of childbearing potential.
Serious warnings
- Hypersensitivity reactions
- Immune Reconstitution Syndrome
- Osteonecrosis
Important Disclaimer
The Ristegra Dispersible Tablets 10 mg Dispersible Tablet professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
